Clinical and Observational Trials

  • Principal Investigator:

    June Y. Hou, MD
    The purpose of this research is to learn about what effects, both good and/or bad, an experimental drug called TransCon IL-2 / has when given by itself SOC chemotherapy, or experimental drug called TransCon TLR7/8 Agonist, or in combination with SOC chemotherapy. TransCon IL-2 / works by blocking the reproduction and spread of cancer cells. The study drugs TransCon IL-2 / and TransCon TLR7/8 Agonist (TLR7/8) have not been approved by the Food and Drug Administration FDA for your type of cancer. We also want to find a dose of TransCon IL-2 / that is safe and tolerable for adult patients who...
  • Principal Investigator:

    Jason D. Wright, MD
    The purpose of this study is to collect vaginal, cervical, and uterine samples for the study during your scheduled surgery. The samples will be collected using cell collection tools similar to how samples are collected during your regular pelvic exams, such as a pap smear to develop a collection method for endometrial sampling which is less invasive and less painful than the current sampling method and develop a test which can be used to identify those patients who are benign for uterine cancer with similar accuracy as current diagnostic methods. This could greatly reduce the patients...

Pages